


SEALEO Revenue
Biotechnology Research • London, England, United Kingdom • 1-10 Employees
SEALEO revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | $25,300 |
Key Contact at SEALEO
Diana Epel
Co-Founder
Company overview
| Headquarters | 58 Wood Lane, Scale Space, London, England W12 7RZ, GB |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
About SEALEO
Sealeo is on a mission to eliminate waste in the pharmaceutical industry by revolutionizing last-mile vaccine delivery. Currently, 50% of vaccines are wasted globally, releasing 2.5 million tonnes of CO2 and claiming the lives of 2-3 million children annually. The main reason for this wastage is inadequate packaging solutions that fail to address the unique challenges of last-mile delivery. On top of this, current solutions continue to rely on materials such as polystyrene and synthetic coolants, which contribute 10 million tons of CO2 annually. Sealeo offers a novel packaging material designed to keep vaccines cold passively, effectively, and affordably. Our fully biodegradable, cost-effective, and lightweight material offers unparalleled adaptability. Its flexibility and moldability allow it to be custom-shaped to the exact dimensions of the medicine being transported, boosting efficiency in last-mile delivery and significantly reducing greenhouse gas emissions.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
SEALEO has 1 employees across 1 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



